vs

Side-by-side financial comparison of Healthpeak Properties (DOC) and Weatherford International plc (WFRD). Click either name above to swap in a different company.

Weatherford International plc is the larger business by last-quarter revenue ($1.2B vs $719.4M, roughly 1.6× Healthpeak Properties). Healthpeak Properties runs the higher net margin — 73.2% vs 9.5%, a 63.7% gap on every dollar of revenue. On growth, Healthpeak Properties posted the faster year-over-year revenue change (3.1% vs -8.3%). Healthpeak Properties produced more free cash flow last quarter ($357.0M vs $85.0M). Over the past eight quarters, Healthpeak Properties's revenue compounded faster (8.9% CAGR vs -9.5%).

Healthpeak Properties, Inc. is an American real estate investment trust that invests in real estate related to the healthcare industry including senior housing, life science, and medical offices. It was organized in 2007 in Maryland and headquartered in Denver, Colorado with offices in Irvine, Nashville and San Francisco. As of December 31, 2019, the company owned interests in 617 properties.

Weatherford International plc is an American multinational oilfield service company, headquartered in the US and operating in 75 countries globally across the oil and natural gas producing regions. The company provides technical equipment and services used for drilling, evaluation, completion, production, and intervention on gas and oil wells.

DOC vs WFRD — Head-to-Head

Bigger by revenue
WFRD
WFRD
1.6× larger
WFRD
$1.2B
$719.4M
DOC
Growing faster (revenue YoY)
DOC
DOC
+11.4% gap
DOC
3.1%
-8.3%
WFRD
Higher net margin
DOC
DOC
63.7% more per $
DOC
73.2%
9.5%
WFRD
More free cash flow
DOC
DOC
$272.0M more FCF
DOC
$357.0M
$85.0M
WFRD
Faster 2-yr revenue CAGR
DOC
DOC
Annualised
DOC
8.9%
-9.5%
WFRD

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
DOC
DOC
WFRD
WFRD
Revenue
$719.4M
$1.2B
Net Profit
$114.0M
$109.0M
Gross Margin
Operating Margin
17.4%
10.7%
Net Margin
73.2%
9.5%
Revenue YoY
3.1%
-8.3%
Net Profit YoY
2406.4%
-21.6%
EPS (diluted)
$0.16
$1.49

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DOC
DOC
WFRD
WFRD
Q1 26
$1.2B
Q4 25
$719.4M
$1.3B
Q3 25
$705.9M
$1.2B
Q2 25
$694.3M
$1.2B
Q1 25
$702.9M
$1.2B
Q4 24
$698.0M
$1.3B
Q3 24
$700.4M
$1.4B
Q2 24
$695.5M
$1.4B
Net Profit
DOC
DOC
WFRD
WFRD
Q1 26
$109.0M
Q4 25
$114.0M
$138.0M
Q3 25
$-117.1M
$81.0M
Q2 25
$31.7M
$136.0M
Q1 25
$42.8M
$76.0M
Q4 24
$4.5M
$112.0M
Q3 24
$85.9M
$157.0M
Q2 24
$146.0M
$125.0M
Gross Margin
DOC
DOC
WFRD
WFRD
Q1 26
Q4 25
Q3 25
58.6%
Q2 25
60.2%
Q1 25
61.1%
Q4 24
60.3%
Q3 24
60.0%
Q2 24
60.6%
Operating Margin
DOC
DOC
WFRD
WFRD
Q1 26
10.7%
Q4 25
17.4%
15.4%
Q3 25
9.2%
14.4%
Q2 25
5.7%
19.7%
Q1 25
7.7%
11.9%
Q4 24
-2.2%
14.8%
Q3 24
14.1%
17.2%
Q2 24
22.3%
18.8%
Net Margin
DOC
DOC
WFRD
WFRD
Q1 26
9.5%
Q4 25
73.2%
10.7%
Q3 25
-16.6%
6.6%
Q2 25
4.6%
11.3%
Q1 25
6.1%
6.4%
Q4 24
0.7%
8.4%
Q3 24
12.3%
11.1%
Q2 24
21.0%
8.9%
EPS (diluted)
DOC
DOC
WFRD
WFRD
Q1 26
$1.49
Q4 25
$0.16
$1.91
Q3 25
$-0.17
$1.12
Q2 25
$0.05
$1.87
Q1 25
$0.06
$1.03
Q4 24
$0.02
$1.53
Q3 24
$0.12
$2.06
Q2 24
$0.21
$1.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DOC
DOC
WFRD
WFRD
Cash + ST InvestmentsLiquidity on hand
$467.5M
$1.0B
Total DebtLower is stronger
$9.8B
$1.5B
Stockholders' EquityBook value
$7.5B
$1.8B
Total Assets
$20.3B
Debt / EquityLower = less leverage
1.31×
0.84×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DOC
DOC
WFRD
WFRD
Q1 26
$1.0B
Q4 25
$467.5M
$987.0M
Q3 25
$91.0M
$967.0M
Q2 25
$89.4M
$943.0M
Q1 25
$70.6M
$873.0M
Q4 24
$119.8M
$916.0M
Q3 24
$180.4M
$920.0M
Q2 24
$106.9M
$862.0M
Total Debt
DOC
DOC
WFRD
WFRD
Q1 26
$1.5B
Q4 25
$9.8B
$1.5B
Q3 25
$9.1B
$1.5B
Q2 25
$9.0B
$1.6B
Q1 25
$8.9B
$1.6B
Q4 24
$8.7B
$1.6B
Q3 24
$8.6B
$1.6B
Q2 24
$8.6B
$1.6B
Stockholders' Equity
DOC
DOC
WFRD
WFRD
Q1 26
$1.8B
Q4 25
$7.5B
$1.7B
Q3 25
$7.6B
$1.6B
Q2 25
$7.9B
$1.5B
Q1 25
$8.2B
$1.4B
Q4 24
$8.4B
$1.3B
Q3 24
$8.6B
$1.3B
Q2 24
$8.8B
$1.2B
Total Assets
DOC
DOC
WFRD
WFRD
Q1 26
Q4 25
$20.3B
$5.2B
Q3 25
$19.6B
$5.3B
Q2 25
$19.8B
$5.1B
Q1 25
$19.8B
$5.1B
Q4 24
$19.9B
$5.2B
Q3 24
$20.0B
$5.2B
Q2 24
$20.2B
$5.1B
Debt / Equity
DOC
DOC
WFRD
WFRD
Q1 26
0.84×
Q4 25
1.31×
0.86×
Q3 25
1.20×
0.94×
Q2 25
1.14×
1.04×
Q1 25
1.08×
1.17×
Q4 24
1.04×
1.26×
Q3 24
1.00×
1.21×
Q2 24
0.98×
1.33×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DOC
DOC
WFRD
WFRD
Operating Cash FlowLast quarter
$1.3B
$136.0M
Free Cash FlowOCF − Capex
$357.0M
$85.0M
FCF MarginFCF / Revenue
49.6%
7.4%
Capex IntensityCapex / Revenue
124.4%
4.7%
Cash ConversionOCF / Net Profit
10.99×
1.25×
TTM Free Cash FlowTrailing 4 quarters
$470.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DOC
DOC
WFRD
WFRD
Q1 26
$136.0M
Q4 25
$1.3B
$268.0M
Q3 25
$315.0M
$138.0M
Q2 25
$363.5M
$128.0M
Q1 25
$279.4M
$142.0M
Q4 24
$1.1B
$249.0M
Q3 24
$318.2M
$262.0M
Q2 24
$316.2M
$150.0M
Free Cash Flow
DOC
DOC
WFRD
WFRD
Q1 26
$85.0M
Q4 25
$357.0M
$217.0M
Q3 25
$94.0M
Q2 25
$74.0M
Q1 25
$65.0M
Q4 24
$333.7M
$149.0M
Q3 24
$184.0M
Q2 24
$88.0M
FCF Margin
DOC
DOC
WFRD
WFRD
Q1 26
7.4%
Q4 25
49.6%
16.8%
Q3 25
7.6%
Q2 25
6.1%
Q1 25
5.4%
Q4 24
47.8%
11.1%
Q3 24
13.1%
Q2 24
6.3%
Capex Intensity
DOC
DOC
WFRD
WFRD
Q1 26
4.7%
Q4 25
124.4%
4.0%
Q3 25
3.6%
Q2 25
4.5%
Q1 25
6.5%
Q4 24
105.6%
7.5%
Q3 24
5.5%
Q2 24
4.4%
Cash Conversion
DOC
DOC
WFRD
WFRD
Q1 26
1.25×
Q4 25
10.99×
1.94×
Q3 25
1.70×
Q2 25
11.48×
0.94×
Q1 25
6.52×
1.87×
Q4 24
235.43×
2.22×
Q3 24
3.71×
1.67×
Q2 24
2.17×
1.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DOC
DOC

Segment breakdown not available.

WFRD
WFRD

Middle East/North Africa/Asia$556.0M48%
Other$360.0M31%
Europe/Sub-Sahara Africa/Russia$236.0M20%

Related Comparisons